Intensive Diabetes Management: Implications of the DCCT and UKPDS

The Diabetes Educator

Volumn 28, Issue 5, 2002, Pages 735-740

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; INTENSIVE CARE; METABOLISM; METHODOLOGY; NURSE ATTITUDE; PATIENT EDUCATION; PRACTICE GUIDELINE; SELF CARE; STANDARD;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES COMPLICATIONS; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INTENSIVE CARE; NURSE'S ROLE; PATIENT EDUCATION; SELF CARE;

EID: 0642345259     PISSN: 01457217     EISSN: None     Source Type: Journal    
DOI: 10.1177/014572170202800514     Document Type: Article

References (12)

1. Centers for Disease Control and Prevention, Na-tional Center for Chronic Disease Prevention and Health Promotion. National Diabetes Fact Sheet. March 27, 2002.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
3. Harris Ml, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999;22:403-408.
4. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2001; 24(suppl 1): S33-S43.
5. Harris Ml. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care. 2000;23:754-758.
6. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
7. United Kingdom Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
8. United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
9. Diabetes Control and Complications Trial Research Group. Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabe-tes Care. 1995;18:1468-1478.
10. Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1 c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995: 44:968-983.
11. American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care. 1998:21:2180-2184.
12. Kramer JR, Jacobson AM, Ryan CM, Murphy WD, and the DCCT Research Group. Psychologi-cal aspects of the Diabetes Control and Complications Trial. In: Bradley C, Home P, Christie M, eds. The Technology of Diabetes Care: Converging Medical and Psychosocial Perspectives. Harwood Academic Publishers; 1991:122-139.